Published in J Exp Med on January 01, 1979
Regulation of granulomatous inflammation in murine schistosomiasis. In vitro characterization of T lymphocyte subsets involved in the production and suppression of migration inhibition factor. J Exp Med (1980) 1.48
Selective suppression of the major idiotypic component of an antihapten response by soluble T cell-derived factors with idiotypic or anti-idiotypic receptors. J Exp Med (1980) 1.47
Regulation of granulomatous inflammation in murine schistosomiasis. II. T suppressor cell-derived, I-C subregion-encoded soluble suppressor factor mediates regulation of lymphokine production. J Exp Med (1983) 0.91
Interferon inhibits the generation of allospecific suppressor T lymphocytes. J Exp Med (1982) 0.84
Regulatory mechanisms in cell-mediated immune responses. VIII. Differential expression of I-region determinants by suppressor cells and their targets in suppression of mixed leukocyte reactions. J Exp Med (1979) 0.81
Regulatory mechanisms in cell-mediated immune responses. Role of I-J and I-C determinants in the activation of H-2I and H-2K/D alloantigen-specific suppressor T cells. J Exp Med (1983) 0.79
Suppressive mechanisms in alloantigen-induced T cell responses. J Exp Med (1983) 0.79
Murine T cell Ia antigens: specificity Iat.46 maps in I-J to I-E chromosomal segment of H-2 complex. Proc Natl Acad Sci U S A (1980) 0.79
Cyclosporin A-treated guinea pig responder cells secrete a genetically restricted factor that suppresses the mixed leukocyte reaction. J Clin Invest (1983) 0.76
A new I subregion (I-J) marked by a locus (Ia-4) controlling surface determinants on suppressor T lymphocytes. J Exp Med (1976) 6.11
Regulatory mechanisms in cell-mediated immune responses. III. I-region control of suppressor cell interaction with responder cells in mixed lymphocyte reactions. J Exp Med (1976) 2.24
Regulatory mechanisms in cell-mediated immune responses. II. A genetically restricted suppressor of mixed lymphocyte reactions released by alloantigen-activated spleen cells. J Exp Med (1975) 2.18
Suppressor T cells in cell-mediated immunity. Br Med Bull (1976) 2.13
Enrichment of specific suppressor T cells and characterization of their surface markers. J Exp Med (1977) 2.13
Immunosuppressive factor(s) specific for L-glutamic acid50-L-tyrosine50 (GT) II. Presence of I-J determinants on the GT-suppressive factor. J Exp Med (1977) 2.12
The I-J subregion codes for determinats on suppressor factor(s) which limit the contact sensitivity response to picryl chloride. J Exp Med (1977) 2.07
Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum. Proc Natl Acad Sci U S A (1977) 1.93
Regulation of the immune response: production of a soluble suppressor by immune spleen cells in vitro. J Immunol (1975) 1.85
Suppressor-cell induction in vitro. IV. Target of antigen-specific suppressor factor and its genetic relationships. J Exp Med (1978) 1.77
Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts. J Immunol (1977) 1.76
Specific enrichment of the suppressor T cell bearing I-J determinants: parallel functional and serological characterizations. J Exp Med (1977) 1.70
Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells. J Immunol (1976) 1.47
Potentiation of a primary in vivo antibody response by alloantisera against gene products of the I region of the H-2 complex. Proc Natl Acad Sci U S A (1977) 1.36
Serologic and biochemical studies of the Ia system of the mouse H-2 gene complex. Further evidence for I-C subregion. J Immunol (1975) 1.36
Regulatory mechanisms in cell-mediated immune responses. IV. Expression of a receptor for mixed lymphocyte reaction suppressor factor on activated T lymphocytes. J Exp Med (1976) 1.27
In vitro analysis of allogeneic lymphocyte interaction. I. Characterization and cellular origin of an Ia-positive helper factor-allogeneic effect factor. J Exp Med (1977) 1.26
Murine Ia antigens: identification and mapping of Ia.23 and further definition of the I-E subregion. J Immunol (1978) 1.18
The role of gene products of the I-J subregion in mixed lymphocyte reactions. J Exp Med (1977) 1.12
Regulatory mechanisms in cell-mediated immune responses. VI. Interaction of H-2 and non-H-2 genes in elaboration of mixed leukocyte reaction suppressor factor. J Exp Med (1977) 0.98
Lymphocyte antigens controlled by the Ir region of the mouse H-2 complex. Transplantation (1974) 0.96
Immunochemical evidence for three Ia loci in the I-region of the H-2 complex. J Exp Med (1977) 0.96
A new lymphocyte-activating determinant locus expressed on T cells, and mapping in I-C subregion. J Exp Med (1978) 0.88
Regulatory substances produced by lymphocytes--IV. Further characterization of the inhibitor of DNA synthesis (IDS). Immunochemistry (1977) 0.87
Cellular basis of tolerance to serum albumin in adult mice. I. characterization of T suppressor and T helper cells. J Immunol (1978) 0.85
The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization. Adv Immunol (1975) 9.19
Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med (1981) 5.76
Antigen-specific T-cell factor in cell cooperation. Mapping within the I region of the H-2 complex and ability to cooperate across allogeneic barriers. J Exp Med (1975) 4.64
New lymphocyte antigen system (Lna) controlled by the Ir region of the mouse H-2 complex. Proc Natl Acad Sci U S A (1973) 4.45
Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med (1971) 4.41
Genes required for cytotoxicity against virus-infected target cells in K and D regions of H-2 complex. Nature (1975) 4.41
Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci U S A (1993) 3.57
Evidence for the expression of Ia (H-2-associated) antigens on thymus-derived lymphocytes. J Exp Med (1974) 3.56
Biological expressions of lymphocyte activation. II. Generation of a population of thymus-derived suppressor lymphocytes. J Exp Med (1973) 3.50
Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet (1995) 3.29
Biological expressions of lymphocyte activation. 3. Suppression of plaque-forming cell responses in vitro by supernatant fluids from concanavalin A-activated spleen cell cultures. J Immunol (1974) 3.27
Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet (1999) 3.15
Class II MHC molecules are specific receptors for staphylococcus enterotoxin A. Science (1989) 3.03
Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet (1988) 2.88
Risk of recurrent seizures after two unprovoked seizures. N Engl J Med (1998) 2.74
T lymphocyte-enriched murine peritoneal exudate cells. III. Inhibition of antigen-induced T lymphocyte Proliferation with anti-Ia antisera. J Immunol (1976) 2.64
H-2 haplotypes, genes and antigens: second listing. II. The H-2 complex. Immunogenetics (1983) 2.62
A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci U S A (1998) 2.31
Regulatory mechanisms in cell-mediated immune responses. I. Regulation of mixed lymphocyte reactions by alloantigen-activated thymus-derived lymphocytes. J Exp Med (1974) 2.26
Regulatory mechanisms in cell-mediated immune responses. III. I-region control of suppressor cell interaction with responder cells in mixed lymphocyte reactions. J Exp Med (1976) 2.24
Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst (1997) 2.21
Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J Exp Med (1986) 2.18
Regulatory mechanisms in cell-mediated immune responses. II. A genetically restricted suppressor of mixed lymphocyte reactions released by alloantigen-activated spleen cells. J Exp Med (1975) 2.18
Membrane molecules determined by the H-2 associated immune response region: isolation and some properties. Proc Natl Acad Sci U S A (1974) 2.17
Serologic and genetic aspects of murine Ia antigens. Transplant Rev (1976) 2.02
Specific amplification with PCR of a refractory segment of genomic DNA. Nucleic Acids Res (1988) 2.00
Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J Immunol (1985) 1.98
Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1. J Exp Med (1996) 1.95
Serological and functional evidence for further subdivision of the I regions of the H-2 gene complex. Cold Spring Harb Symp Quant Biol (1977) 1.91
Homozygous parent affected sib pair method for detecting disease predisposing variants: application to insulin dependent diabetes mellitus. Genet Epidemiol (1993) 1.91
Patients' fear of genetic discrimination by health insurers: the impact of legal protections. Genet Med (2001) 1.90
Ethnic differences in asthma and associated phenotypes: collaborative study on the genetics of asthma. J Allergy Clin Immunol (2001) 1.89
Antigen presentation by major histocompatibility complex class I-B molecules. Annu Rev Immunol (1994) 1.86
Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans. Ann Hum Genet (2009) 1.85
The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study. Diabetologia (2005) 1.84
Seizure recurrence after a 1st unprovoked seizure: an extended follow-up. Neurology (1990) 1.76
Laws restricting health insurers' use of genetic information: impact on genetic discrimination. Am J Hum Genet (2000) 1.74
A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet (1995) 1.74
Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am J Hum Genet (2000) 1.72
Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J Natl Cancer Inst (1994) 1.69
Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes (2001) 1.69
HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med (1996) 1.66
A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin Invest (1993) 1.66
Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer (1997) 1.63
Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes (1997) 1.60
I-region-associated determinants: expression on mitogen-stimulated lymphocytes and detection by cytotoxic T cells. Eur J Immunol (1975) 1.58
Specialized role for a murine class I-b MHC molecule in prokaryotic host defenses. Science (1992) 1.57
Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens). Neurology (1986) 1.55
Inhibition of dual Ir gene-controlled T-lymphocyte proliferative response to poly (Glu56Lys35Phe9)n with anti-Ia antisera directed against products of either I-A or I-C subregion. Proc Natl Acad Sci U S A (1978) 1.55
Possible role of V beta T cell receptor genes in susceptibility to collagen-induced arthritis in mice. J Exp Med (1988) 1.55
Accuracy of proband reported family history: the NHLBI Family Heart Study (FHS). Genet Epidemiol (1999) 1.54
Biological expressions of lymphocyte activation. IV. Concanavalin A-activated suppressor cells in mouse mixed lymphocyte reactions. J Immunol (1975) 1.54
Evidence for major genes influencing pulmonary function in the NHLBI family heart study. Genet Epidemiol (2000) 1.54
Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis. Arthritis Rheum (1973) 1.53
Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule. J Immunol (1985) 1.53
Effect of transfer factor on lymphocyte function in anergic patients. J Clin Invest (1972) 1.52
Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum (1984) 1.52
Genomewide screen and identification of gene-gene interactions for asthma-susceptibility loci in three U.S. populations: collaborative study on the genetics of asthma. Am J Hum Genet (2001) 1.50
Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype. J Immunol (1991) 1.50
Evidence for more than one Ia antigenic specificity on molecules determined by the I-A subregion of the mouse major histocompatibility complex. J Immunol (1976) 1.49
Regulation of granulomatous inflammation in murine schistosomiasis. In vitro characterization of T lymphocyte subsets involved in the production and suppression of migration inhibition factor. J Exp Med (1980) 1.48
Risk of diabetes in siblings of index cases with Type 2 diabetes: implications for genetic studies. Diabet Med (2002) 1.47
Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2. Am J Hum Genet (2000) 1.47
Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Infect Immun (1993) 1.47
Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells. J Immunol (1976) 1.47
HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J Exp Med (1996) 1.46
Genetic organization and evolution of the mouse H-2 region: a duplication model. Transplant Proc (1971) 1.44
Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis. J Infect Dis (1971) 1.43
Localization of the autosomal dominant HLA-linked spinocerebellar ataxia (SCA1) locus, in two kindreds, within an 8-cM subregion of chromosome 6p. Am J Hum Genet (1991) 1.43
Epidemiology of IDDM. Is it needed? Diabetes Care (1989) 1.42
Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. Am J Physiol Gastrointest Liver Physiol (2007) 1.42
Genetic epidemiology of subclinical cardiovascular disease in the diabetes heart study. Ann Hum Genet (2008) 1.41
Validation study of self-reported measures of fat distribution. Int J Obes Relat Metab Disord (1996) 1.39
Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes. Infect Immun (1994) 1.39
Serological and biochemical identification of hybrid Ia antigens. J Exp Med (1980) 1.38
Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today (1995) 1.38
Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc (1984) 1.37
Serologic and biochemical studies of the Ia system of the mouse H-2 gene complex. Further evidence for I-C subregion. J Immunol (1975) 1.36
Reconstitution of Ir genes, Ia antigens, and mixed lymphocyte reaction determinants by gene complementation. Proc Natl Acad Sci U S A (1981) 1.35
New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes (1997) 1.35
A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int (2006) 1.34
Regulation of autoimmune response to mouse thyroglobulin: influence of H-2D-end genes. J Immunol (1979) 1.34
Demonstration by MLR test of a previously unsuspected intra-H-2 crossover in the B10.HTT strain: implications concerning location of MLR determinants in the Ir region. Transplant Proc (1973) 1.33
Specialized functions of MHC class I molecules. I. An N-formyl peptide receptor is required for construction of the class I antigen Mta. J Exp Med (1990) 1.32
Environmental factors can confound identification of a major gene effect: results from a segregation analysis of a simulated population of lung cancer families. Genet Epidemiol (1998) 1.32
Bone marrow cell transplants involving intra-H-2 recombinant inbred mouse strains. Evidence that hemopoietic histocompatibility-1 (Hh-1) genes are distinct from H-2D or H-2L. J Immunol (1988) 1.32
The presence of I-region-associated antigens on B cells in molecules distinct from immunoglobulin and H-2K and H-2D. Proc Natl Acad Sci U S A (1974) 1.31
Dissociation of the stimulatory activities of staphylococcal enterotoxins for T cells and monocytes. J Exp Med (1990) 1.29
Influence of complement C5 and V beta T cell receptor mutations on susceptibility to collagen-induced arthritis in mice. J Immunol (1989) 1.29
Genetic linkage and transmission disequilibrium of marker haplotypes at chromosome 1q41 in human systemic lupus erythematosus. Arthritis Res (2001) 1.28
Identification of T-cell receptor V beta deletion mutant mouse strain AU/ssJ (H-2q) which is resistant to collagen-induced arthritis. Immunogenetics (1989) 1.28
Regulatory mechanisms in cell-mediated immune responses. IV. Expression of a receptor for mixed lymphocyte reaction suppressor factor on activated T lymphocytes. J Exp Med (1976) 1.27
Interactions of Fc receptors with antibodies against Ia antigens and other cell surface components. J Exp Med (1975) 1.27
Evidence for a novel gene for familial febrile convulsions, FEB2, linked to chromosome 19p in an extended family from the Midwest. Hum Mol Genet (1998) 1.26